Arterial gas embolism is one of the original HBOT emergencies. The treatment is older than the FDA recognition itself, dating to US Navy diving medicine in the 1960s.
This page lays out the evidence for HBOT in AGE, the Treatment Table 6 standard that drives care, and how the case mix has shifted from diving to iatrogenic causes.
Quick Facts
| Field | Value |
|---|---|
| FDA approval status | Recognized indication (one of 14) |
| UHMS classification | Tier 1 — approved indication |
| Typical protocol | US Navy Treatment Table 6, 2.8 ATA initial, 4-6 hour session |
| Medicare coverage | Covered under LCD L33532, 2025 as emergency care |
| Insurance prior auth | Waived; emergency intervention |
| Evidence grade | GRADE B (large case series, strong mechanism, no RCT possible) |
The evidence
The AGE HBOT data rests on a long line of case series and registry data. No randomized trial exists because the condition is too severe and rare for trial design.
The Bessereau Intensive Care Medicine cohort, 2010, PMID 20221749 is the largest modern data point. The Paris referral center series of 119 iatrogenic AGE patients reported 21% one-year mortality and showed that early HBOT was linked to better outcomes.
The Blanc 2002 review on massive arterial air embolism in cardiac surgery, PMID 10096979 reported on outcomes after HBOT for cardiac-surgery air embolism. Survivors had earlier HBOT start times than non-survivors.
The Murphy-Lavoie StatPearls reference on diving gas embolism, 2024 sums up the modern standard of care. The US Navy Treatment Table 6 remains the anchor protocol.
A PMC 2023 individual patient data meta-analysis on iatrogenic AGE pooled 16 observational studies covering 696 patients. Early HBOT was linked to a higher rate of favorable outcomes versus delayed HBOT.
The StatPearls 2024 reference on AGE describes the standard emergency-medicine approach.
A 2017 case report on delayed HBOT after 39-hour gap, PMID 28763175 reported a favorable outcome despite long delay. The case supports HBOT even outside the 6-hour window in selected patients.
The DAN diving medical guidelines, current 2026 cover field care for divers with suspected AGE. Surface oxygen and rapid transfer to a chamber are the standard prehospital care.
The Mathieu 2017 review on HBO and gas embolism, PMID 17439698 framed the standard for chamber treatment timing and protocol selection.
A 2021 study on seizures in iatrogenic cerebral AGE, PMID 34414374 examined the neurological complications and recovery patterns after HBOT.
The UHMS chapter on air or gas embolism lays out the formal indication. The Society backs HBOT as standard care for AGE regardless of cause.
The England NHS 2018 commissioning policy on HBOT for decompression illness and gas embolism describes the standard treatment framework used in the UK.
The pattern is consistent. Earlier HBOT is linked to better outcomes in AGE. The case for treatment is built on mechanism, large case series, and the absence of any reasonable alternative.
Mechanism of action
Gas embolism happens when gas bubbles enter the arterial blood. The bubbles can lodge in small arteries in the brain, heart, or other organs and block blood flow.
Each bubble starves the tissue downstream of oxygen. Brain cells die within minutes. Heart muscle starves at a similar rate.
Hyperbaric oxygen attacks the problem on two fronts. First, pressure crushes the bubbles to about 40% of their original size at 60 feet of sea water. Smaller bubbles can pass through small arteries and reach tissue that needs blood flow.
Second, the high oxygen environment helps the starved tissue. Plasma oxygen rises high enough to feed cells by diffusion, even where blood flow is still poor.
HBOT also blunts the reperfusion injury that follows blood flow return. The wave of free radicals released when blood flow returns can kill cells that survived the initial blockage; oxygen breathing under pressure changes that response.
The mechanism explains the time pressure. Bubbles dissolve in venous blood over hours, but the tissue they starved is dying in minutes. HBOT must start before too much tissue dies.
Typical protocol
US Navy Treatment Table 6 is the standard. The plan starts at 2.8 ATA (60 feet of sea water) and uses 100% oxygen breathing periods broken up by short air breaks.
The full Table 6 runs about 4 hours and 45 minutes. Patients with severe or persistent symptoms may convert to Table 6A, which adds a deep excursion to 165 feet of sea water early in the session.
Many patients need only one Table 6 session if response is rapid. Patients with persistent neurological symptoms may need follow-up sessions on a daily schedule for several days.
Treatment must start as soon as AGE is suspected. The 6-hour window is the conservative target. Some centers will still treat patients arriving 12 to 24 hours after onset because the alternative is no treatment.
Insurance and cost
Medicare covers AGE under CMS NCD 20.29, 2017 and the related LCD L33532. Cover is straightforward as emergency care.
Cost per Table 6 session runs $2,000 to $5,000 because of the long session length and intensive care setup. Most patients have only one or two sessions, so total cost is contained.
Commercial insurance follows Medicare for emergency AGE. Prior auth is waived. Plans process claims after the fact based on the diagnosis and treatment notes.
Most patients are critically ill at the time of treatment. The HBOT bill is folded into the larger hospital care cost, and patients do not face out-of-pocket questions until the hospital stay is settled.
Where to get it
AGE HBOT runs at hospital-based hyperbaric centers attached to trauma or cardiac hospitals. The center must have a Table 6-capable chamber and 24-hour staffing.
The UHMS-accredited facility directory, current 2026 lists qualified centers. The subset with 24-hour emergency intake is smaller.
DAN — Divers Alert Network — runs a 24-hour emergency hotline that can identify the nearest qualified chamber. For diving cases, DAN coordination is part of standard care.
For chamber type details, see our FDA-cleared chambers list. AGE care needs a multiplace chamber that can reach 2.8 ATA and hold a critically ill patient with care lines.
The geography is uneven. Most large metro areas have at least one Table 6-capable chamber. Rural patients with suspected AGE are usually transferred by air, which adds to the treatment delay.
See our UHMS accreditation primer for what the credential means.
Limitations and contraindications
Untreated lung collapse is an absolute limit. Cardiac-surgery AGE patients often have post-op lung issues that need chest imaging before chamber treatment.
Unstable blood pressure or arrhythmia is a relative limit. The chamber environment slows acute care, and the team must judge whether the patient can tolerate the long session.
Patients with severe lung disease may struggle with the long oxygen exposure. Oxygen toxicity can show up as seizures during Table 6 sessions, especially in patients with reduced lung function.
The harder limit is timing. By the time many patients are diagnosed, hours have passed and brain tissue has already died. HBOT cannot bring back dead tissue.
The 2010 Bessereau cohort showed that 21% one-year mortality despite HBOT. The data is not a measure of HBOT failure — it reflects the severity of AGE itself. Without HBOT, the outcome would likely be worse.
Active research
ClinicalTrials.gov studies on AGE HBOT, current 2026 cover plans for cardiac-surgery prevention, dialysis-related cases, and outcomes registries.
A focus area is iatrogenic AGE prevention. Most modern AGE cases come from medical procedures — cardiac surgery, dialysis, central line placement — and improved technique can cut the rate.
Another focus is the role of HBOT in delayed presentations, where the standard 6-hour window has closed.
How this compares to off-label HBOT uses
AGE is one of the most settled FDA-listed HBOT uses. The mechanism is direct (gas bubble compression), the Table 6 protocol is decades old, and the role is settled as primary emergency care.
This is very different from off-label HBOT for non-emergency conditions. AGE HBOT addresses a specific physical problem — gas bubbles in arteries — that responds to a specific physical intervention (pressure). Off-label uses for anti-aging or recovery do not target such a clear physical problem.
For context on how off-label HBOT marketing splits from clinical data, read our analysis of institutional silence on HBOT and our decompression sickness evidence atlas, the sister indication that uses the same Table 6 protocol.
The honest summary: HBOT for AGE is the original FDA-recognized use. The case for treatment is built on physics, large case series, and the absence of any reasonable alternative.
Frequently asked questions
How fast does treatment need to start?
The strongest data supports starting within 6 hours of symptom onset. Many centers still treat patients arriving 12 to 24 hours after onset because the alternative is no treatment. After 48 hours, the case for HBOT becomes thin in most patients.
Where do most AGE cases come from now?
Iatrogenic cases — from cardiac surgery, dialysis, central line placement, and other medical procedures — are the main source in modern series. Diving cases still happen but are less common in US centers than in coastal hyperbaric programs.
Will insurance cover this?
Yes. AGE is treated as emergency care under Medicare and most commercial plans. Prior auth is waived. The hospital handles the claim based on the diagnosis and treatment notes.
How many sessions are needed?
Many patients have only one Table 6 session if response is rapid. Patients with persistent neurological symptoms may need several more sessions on a daily schedule. Most patients have 1 to 5 sessions total.
Can a soft-shell wellness chamber treat AGE?
No. AGE care asks for 2.8 ATA in a multiplace chamber that can hold a critically ill patient with care lines. Soft-shell chambers reach only 1.3 ATA. They cannot crush the bubbles that drive AGE.
Sources
- Bessereau Intensive Care Medicine Cohort, 2010
- Blanc Cardiac AGE Review, 2002
- Murphy-Lavoie StatPearls Diving Gas Embolism, 2024
- PMC IPD Meta-analysis Iatrogenic AGE, 2023
- StatPearls Arterial Gas Embolism, 2024
- Delayed HBOT 39-hour Case, 2017
- DAN Diving Medical Resources, 2026
- Mathieu HBO Gas Embolism Review, 2017
- Seizures in Cerebral AGE Study, 2021
- UHMS Air or Gas Embolism Chapter, current
- NHS HBOT Decompression Gas Embolism Policy, 2018
- CMS NCD 20.29 Hyperbaric Oxygen Therapy, 2017
- CMS LCD L33532, 2025
Medical disclaimer
This page is medical journalism, not medical advice. Arterial gas embolism is a life-threatening emergency that needs hospital-based care at a center with chamber capacity. HBOT is the standard treatment but does not work in every patient. Call 911 or DAN if you suspect AGE in a diver or post-procedure patient.